Adocia Société Anonyme, a clinical-stage biotechnology company, develops medicines for the treatment of diabetes from already-approved therapeutic molecules. Its proprietary BioChaperone technological platform is designed and developed from polymers, oligomers, and small organic compounds to enhance the effectiveness and/or safety of therapeutic proteins. The companys clinical product pipeline includes four insulin formulations, including BioChaperone Lispro U100 and U200, which are ultra-rapid formulations of insulin analogs; HinsBet U100, rapid-acting formulation of human insulin; and BioChaperone Combo, a combination of basal insulin glargine and rapid-acting insulin lispro. It is also developing six preclinical products, such as BioChaperone Human Glucagon, an aqueous formulation of human glucagon; BioChaperone Glargine Dulaglutide and BioChaperone Glargine Liraglutide that are combinations of insulin glargine with GLP-1s; BioChaperone Lispro Pramlintide and BioChaperone Lispro Exenatide, which are combinations of insulin lispro with synergistic prandial hormones; and HinsBet U500, a concentrated, rapid-acting formulation of human insulin. The company was founded in 2005 and is headquartered in Lyon, France.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Tobacco products
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:ADOCY
CUSIPN/A
Phone33-04-72-61-06-10
Debt
Debt-to-Equity Ratio0.11
Current Ratio3.12
Quick Ratio3.12
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$21.99 million
Price / Sales6.36
Cash Flow$118.8235 per share
Price / Cash0.17
Book Value$6.90 per share
Price / Book2.93
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees123
Outstanding Shares6,920,000
Market Cap$136.32 million
ADOCIA/S (OTCMKTS:ADOCY) Frequently Asked Questions
What is ADOCIA/S's stock symbol?
ADOCIA/S trades on the OTCMKTS under the ticker symbol "ADOCY."
Who are some of ADOCIA/S's key competitors?
Has ADOCIA/S been receiving favorable news coverage?
Media headlines about ADOCY stock have trended somewhat positive on Thursday, Accern reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. ADOCIA/S earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave news coverage about the company an impact score of 46.57 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future. View Recent Headlines for ADOCIA/S.
How do I buy shares of ADOCIA/S?
Shares of ADOCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ADOCIA/S's stock price today?
One share of ADOCY stock can currently be purchased for approximately $20.20.
How big of a company is ADOCIA/S?
ADOCIA/S has a market capitalization of $136.32 million and generates $21.99 million in revenue each year. The company earns $-8,730,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. ADOCIA/S employs 123 workers across the globe.
How can I contact ADOCIA/S?
ADOCIA/S's mailing address is 115 avenue Lacassagne, Lyon I0, 69003. The company can be reached via phone at 33-04-72-61-06-10 or via email at [email protected]
MarketBeat Community Rating for ADOCIA/S (OTCMKTS ADOCY)
MarketBeat's community ratings are surveys of what our community members think about ADOCIA/S and other stocks. Vote "Outperform" if you believe ADOCY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ADOCY will underperform the S&P 500 over the long term. You may vote once every thirty days.
